2026 NPPES data Hematology & Oncology Physician NPI 1902854904 M.D.
Verify on CMS →

Rajesh Surapaneni, M.D.

Hematology & Oncology Physician in Camp Hill, Pennsylvania.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
853
Medicare Part D claims · 126 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published

What the federal data shows

Rajesh Surapaneni, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 853 Medicare Part D claims in 2023.

75/100
CMS neutral score · not measured
853
Part D claims, 2023
58%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Rajesh Surapaneni, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

853 ≥ 73rd percentile 73% of 1,370,886 prescribers are in lower value bands

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Rajesh Surapaneni, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Rajesh Surapaneni, M.D.?

CMS neutral score, not measured

NPI registry status

Active

Issued 05/04/2006

NPI 1902854904

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,232 US NPIs in this specialty

Medicare Part D claims

853 1% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

75/100

CMS neutral score, not measured

No category scores published; CMS assigned the performance threshold

Specialty distribution in Pennsylvania

How Hematology & Oncology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers
Student in an Organized Heal…5.6%Pharmacist5%Physical Therapist4.9%Mental Health Counselor3.9%Internal Medicine Physician3.3%Professional Counselor3.2%Hematology & Oncology Physic…0.2%
Largest specialties in Pennsylvania (% of in-state providers)

MIPS score not measured

CMS assigned a neutral 75/100 threshold

CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Rajesh Surapaneni, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 3912 TRINDLE RD, Camp Hill, PA, 17011, with a listed phone of (717) 761-8740. NPI 1902854904 was issued on 05/04/2006.

Medicare Part D records for calendar year 2023 show 853 prescription claims written by this provider, covering 126 Medicare beneficiaries and totaling roughly $4.4 million in drug spend, split 42% brand-name and 58% generic by claim count, with an opioid prescribing rate of 3.6%. On the CMS Merit-based Incentive Payment System, this provider carries a Final Score of 75/100 for the 2023 performance year, but CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score: this is the neutral performance threshold CMS assigns where nothing was scored, so it is not comparable with clinicians whose score was measured.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,232 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3912 TRINDLE RD
Camp Hill, PA 17011

Provider Details

NPI 1902854904
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 05/04/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
CMS neutral threshold · not measured

Reporting: Individual

Hospital and facility affiliations

Facilities where Rajesh Surapaneni, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Penn State Health Medical Group LLC
Harrisburg, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Rajesh Surapaneni, M.D.. To verify Rajesh Surapaneni, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Rajesh Surapaneni, M.D. - brand share 42.0%
Hematology & Oncology Physician average

42% brand-name claims vs 58% generic, on 853 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

853
Total Claims
$4.4M
Total Drug Cost
126
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,182
Total Day Supply
33,330
Brand vs Generic
42% brand / 58% generic
Brand Drug Cost
$4.2M
Generic Drug Cost
$205K
Opioid Claims
31 (3.6% rate)
Antibiotic Claims
13

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
2.10
Gender Split
55% female / 45% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Rajesh Surapaneni, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Hydroxyurea
106
Revlimid
Lenalidomide
78
Dexamethasone
45
Acyclovir
43
Eliquis
Apixaban
38
Calquence
Acalabrutinib Maleate
36
Imbruvica
Ibrutinib
29
Anastrozole
26
Imatinib Mesylate
24
Gabapentin
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Rajesh Surapaneni, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Rajesh Surapaneni, M.D.'s 853 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Surapaneni.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Pennsylvania medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Rajesh Surapaneni, M.D.'s specialty?
Rajesh Surapaneni, M.D. specializes in Hematology & Oncology Physician and practices in Camp Hill, Pennsylvania. Credentials: M.D..
How much does Rajesh Surapaneni, M.D. prescribe under Medicare Part D?
In 2023, Rajesh Surapaneni, M.D. wrote 853 Medicare Part D claims totaling $4.4M in drug costs for 126 beneficiaries.
What is Rajesh Surapaneni, M.D.'s Medicare quality score?
Rajesh Surapaneni, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Rajesh Surapaneni, M.D. located?
Rajesh Surapaneni, M.D. is located at 3912 TRINDLE RD, Camp Hill, PA, 17011. Phone: (717) 761-8740.
What is Rajesh Surapaneni, M.D.'s NPI number?
Rajesh Surapaneni, M.D.'s National Provider Identifier (NPI) is 1902854904, issued on 05/04/2006.
Does Rajesh Surapaneni, M.D. prescribe more brand-name or generic drugs?
Rajesh Surapaneni, M.D.'s prescribing is 42% brand-name and 58% generic drugs by claim count, with $4.2M in brand drug costs.
Does Rajesh Surapaneni, M.D. prescribe opioids?
Yes, Rajesh Surapaneni, M.D. had 31 opioid claims in 2023 with an opioid prescribing rate of 3.6%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Rajesh Surapaneni, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Rajesh Surapaneni, M.D.'s most frequently prescribed drugs include Hydroxyurea, Revlimid, Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Rajesh Surapaneni, M.D. accept Medicare?
Rajesh Surapaneni, M.D. appears in CMS Medicare data with 853 Part D claims and 126 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Rajesh Surapaneni, M.D.'s credentials?
Rajesh Surapaneni, M.D.'s NPI is 1902854904 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.